A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

M. Elvington; Y.X. Huang; B.P. Morgan; F. Qiao; N. van Rooijen; C. Atkinson; S. Tomlinson

doi:10.1182/blood-2011-10-383232

A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

M. Elvington
, Y.X. Huang
, B.P. Morgan
, F. Qiao
, N. van Rooijen
, C. Atkinson
, S. Tomlinson

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	6043-6051
Journal	Blood
Volume	119
Issue number	25
DOIs	https://doi.org/10.1182/blood-2011-10-383232
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1182/blood-2011-10-383232

Cite this

@article{f0943b32a50c4a0bad582cbf24edce01,

title = "A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer",

author = "M. Elvington and Y.X. Huang and B.P. Morgan and F. Qiao and \{van Rooijen\}, N. and C. Atkinson and S. Tomlinson",

year = "2012",

doi = "10.1182/blood-2011-10-383232",

language = "Undefined/Unknown",

volume = "119",

pages = "6043--6051",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "25",

}

TY - JOUR

T1 - A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

AU - Elvington, M.

AU - Huang, Y.X.

AU - Morgan, B.P.

AU - Qiao, F.

AU - van Rooijen, N.

AU - Atkinson, C.

AU - Tomlinson, S.

PY - 2012

Y1 - 2012

U2 - 10.1182/blood-2011-10-383232

DO - 10.1182/blood-2011-10-383232

M3 - Article

C2 - 22442351

SN - 0006-4971

VL - 119

SP - 6043

EP - 6051

JO - Blood

JF - Blood

IS - 25

ER -